Ilan Daskal Insider Trading $BIO BIO-RAD LABORATORIES, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ilan Daskal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ilan Daskal. Ilan Daskal is EVP, CFO in BIO-RAD LABORATORIES, INC. ($BIO) and EVP, Chief Financial Officer in BIO-RAD LABORATORIES, INC. ($BIO) and Executive Vice President & CFO in INTERNATIONAL RECTIFIER CORP /DE/ ($IRF) and EVP & CFO Designee in SUNEDISON, INC. ($SUNE) and EVP, Chief Financial Officer in CEPHEID ($CPHD) and Director in IXIA ($XXIA) and Director in NATUS MEDICAL INC ($BABY).
Ilan Daskal in BIO-RAD LABORATORIES, INC.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Ilan Daskal: EVP, Chief Financial Officer, EVP, CFO
Holdings: 1,157 shares
Current Value: $219,494
Latest Transaction: Apr 09 2021
$BIO Market Capitalization: $5.59B
$BIO Previous Close: $189.71
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ilan Daskal in BIO-RAD LABORATORIES, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BIO, CPHD, IRF, XXIA, BABY, SUNE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 09 2021 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 700 | 0 | 2,100 | |
| Apr 09 2021 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Payment of Exercise | F | 592.23 | 250 | 148,058 | 907 | 1.2 K to 907 (-21.61 %) |
| Apr 09 2021 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Buy | M | 0.00 | 700 | 0 | 1,157 | 457 to 1.2 K (+153.17 %) |
| Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | A | 524.30 | 2,166 | 1,135,634 | 2,166 | |
| Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 2,166 | 0 | 2,166 | |
| Apr 09 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 700 | 0 | 2,800 | |
| Apr 09 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Payment of Exercise | F | 403.06 | 243 | 97,944 | 457 | 700 to 457 (-34.71 %) |
| Apr 09 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Buy | M | 0.00 | 700 | 0 | 700 | 0 to 700 |
| Apr 09 2019 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, CFO | Option Exercise | A | 309.84 | 3,500 | 1,084,440 | 3,500 | |
| Apr 09 2019 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, CFO | Option Exercise | A | 0.00 | 3,500 | 0 | 3,500 |
Page: 1